共 153 条
[1]
Hallek M.(2013)Chronic lymphocytic leukemia: 2013 update on prognosis risk stratification and treatment, Am. J. Hematol. 88 803-816
[2]
Oscier D.(2013)Chronic lymphocytic leukemia. Do we need novel prognostic markers? in Hematology Education: The Education Program for the Annual Congress of the European Hematology Association 7 121-130
[3]
Shahjahani M.(2015)Molecular basis of chronic lymhocytic leukemia diagnosis and prognosis Cell. Oncol. (Dordr.) 38 93-109
[4]
Mohammadiasl J.(2011)Prognostic markers in chronic lymphocytic leukemia Vnitrni Lekarstvi 57 847-857
[5]
Noroozi F.(2014)Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by notch1 mutations Blood 123 4101-4110
[6]
Seghatoleslami M.(2009)Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group J. Clin. Oncol. 27 3994-4001
[7]
Shahrabi M.(2009)Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion TP53 mutation, p53–p21 dysfunction, and miR34a in a prospective clinical trial, Blood 114 2589-2597
[8]
Saba F.(2013)Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia Blood 121 1403-1412
[9]
Saki N.(2014)Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data Am. J. Hematol. 89 249-255
[10]
Motyckova M.(2010)TP53 mutation and survival in chronic lymphocytic leukemia J. Clin. Oncol. 28 4473-4479